Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

LENZ Therapeutics, Inc. (LENZ) Assets (2022 - 2023)

LENZ Therapeutics (LENZ) has disclosed Assets for 2 consecutive years, with $266.2 million as the latest value for Q3 2023.

  • On a quarterly basis, Assets fell 20.49% to $266.2 million in Q3 2023 year-over-year; TTM through Sep 2023 was $266.2 million, a 20.49% decrease, with the full-year FY2022 number at $321.9 million, changed N/A from a year prior.
  • Assets was $266.2 million for Q3 2023 at LENZ Therapeutics, down from $287.0 million in the prior quarter.
  • In the past five years, Assets ranged from a high of $378.6 million in Q1 2022 to a low of $266.2 million in Q3 2023.